$CLRI
Cleartronic, Inc. Stock $clri

$clri Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000109181824000016 Filed on February 14, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2022 Q4
Revenue	$572.0K	$606.0K	$506.7K
YoY Change	12.01%	19.62%	-2.41%
Cost Of Revenue	$108.0K	$95.63K	$77.49K
YoY Change	50.99%	23.41%	-15.99%
Gross Profit	$464.0K	$510.4K	$429.2K
YoY Change	5.66%	18.93%	0.52%
Gross Profit Margin	81.11%	84.22%	84.71%
Selling, General & Admin	$447.5K	$526.2K	$389.7K
YoY Change	23.72%	35.03%	23.15%
% of Gross Profit	96.44%	103.1%	90.81%
Research & Development	$3.044K	$13.56K	$21.82K
YoY Change	52.2%	-37.85%	-55.71%
% of Gross Profit	0.66%	2.66%	5.08%
Depreciation & Amortization	$0.00	$0.00	$1.080K
YoY Change	-100.0%	-100.0%	32.68%
% of Gross Profit	0.0%	0.0%	0.25%
Operating Expenses	$452.0K	$541.1K	$412.6K
YoY Change	23.85%	31.15%	12.57%
Operating Profit	$11.97K	-$30.73K	$16.54K
YoY Change	-83.86%	-285.87%	-72.63%
Interest Expense	$9.360K	$4.350K	$550.00
YoY Change	1276.47%	690.91%	-423.53%
% of Operating Profit	78.19%		3.33%
Other Income/Expense, Net	$9.356K	$48.40K	$549.00
YoY Change	1279.94%	8716.03%	-426.79%
Pretax Income	$21.33K	$17.67K	$17.08K
YoY Change	-71.5%	3.41%	-71.64%
Income Tax
% Of Pretax Income
Net Earnings	$21.33K	$17.67K	$17.08K
YoY Change	-71.5%	3.41%	-71.64%
Net Earnings / Revenue	3.73%	2.92%	3.37%
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	229.2M shares	229.2M shares	228.1M shares
Diluted Shares Outstanding	599.5M shares	599.5M shares	599.3M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$673.6K	$818.5K	$280.2K
YoY Change	74.62%	192.18%	-25.9%
Cash & Equivalents	$673.6K	$818.5K	$280.2K
Short-Term Investments
Other Short-Term Assets	$95.69K	$85.58K	$43.67K
YoY Change	184.62%	95.97%	211.48%
Inventory	$31.17K	$27.65K	$21.10K
Prepaid Expenses	$95.69K	$85.58K	$25.67K
Receivables	$611.5K	$476.6K	$562.8K
Other Receivables	$4.140K	$56.72K	$670.00
Total Short-Term Assets	$1.416M	$1.465M	$908.4K
YoY Change	45.42%	61.28%	32.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$18.28K	$15.17K	$14.06K
YoY Change	6.88%	7.87%	-10.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$262.9K	$160.5K	$67.36K
YoY Change	134.17%	138.25%	0.81%
TOTAL ASSETS
Total Short-Term Assets	$1.416M	$1.465M	$908.4K
Total Long-Term Assets	$262.9K	$160.5K	$67.36K
Total Assets	$1.679M	$1.626M	$975.7K
YoY Change	54.6%	66.6%	29.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$38.43K	$49.54K	$108.2K
YoY Change	-51.84%	-54.19%	-41.97%
Accrued Expenses	$19.14K	$25.27K
YoY Change	-17.64%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.583M	$1.534M	$910.5K
YoY Change	68.89%	68.54%	-9.08%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$52.15K	$68.22K	$99.57K
YoY Change	-51.9%	-31.49%	-30.95%
Total Long-Term Liabilities	$52.15K	$68.22K	$99.57K
YoY Change	-51.89%	-31.49%	-30.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.583M	$1.534M	$910.5K
Total Long-Term Liabilities	$52.15K	$68.22K	$99.57K
Total Liabilities	$1.635M	$1.603M	$1.010M
YoY Change	56.37%	58.68%	-11.83%
SHAREHOLDERS EQUITY
Retained Earnings	-$15.20M	-$15.22M	-$15.28M
YoY Change	-0.02%	-0.37%	-2.29%
Common Stock	$2.291K	$2.291K	$2.288K
YoY Change	0.13%	0.13%	0.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$44.17K	$22.84K	-$34.30K
YoY Change
Total Liabilities & Shareholders Equity	$1.679M	$1.626M	$975.7K
YoY Change	54.6%	66.6%	29.48%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	$21.33K	$17.67K	$17.08K
YoY Change	-71.5%	3.41%	-71.64%
Depreciation, Depletion And Amortization	$0.00	$0.00	$1.080K
YoY Change	-100.0%	-100.0%	32.68%
Cash From Operating Activities	-$88.33K	$378.6K	-$188.0K
YoY Change	-180.37%	-301.36%	953.36%
INVESTING ACTIVITIES
Capital Expenditures	$56.60K	$77.02K
YoY Change	1210.19%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$56.60K	-$77.02K
YoY Change	1210.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	-88.33K	$378.6K	-$188.0K
Cash From Investing Activities	-56.60K	-$77.02K
Cash From Financing Activities	0.000
Net Change In Cash	-144.9K	$301.6K	-$188.0K
YoY Change	-237.26%	-260.4%	720.77%
FREE CASH FLOW
Cash From Operating Activities	-$88.33K	$378.6K	-$188.0K
Capital Expenditures	$56.60K	$77.02K
Free Cash Flow	-$144.9K	$301.6K	-$188.0K
YoY Change	-237.26%	-260.4%	720.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2023Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001362516
CY2023Q3	clri	Due From Related Party Current DueFromRelatedPartyCurrent		usd
CY2023Q4	clri	Due From Related Party Non Current DueFromRelatedPartyNonCurrent		usd
CY2023Q4	us-gaap	Other Assets OtherAssets		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
CY2022Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2022Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
CY2023Q4	us-gaap	Increase Decrease In Notes Receivable Related Parties Current IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent		usd
CY2022Q4	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2022Q4	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets		usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023Q4	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q4	clri	Cancellationof Shares Of Common Stock CancellationofSharesOfCommonStock		usd
CY2022Q4	clri	Series C Convertible Preferred Shares Exchanged For Common Stock SeriesCConvertiblePreferredSharesExchangedForCommonStock		usd
CY2023Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent		usd
CY2023Q4	dei	Document Type DocumentType	10-Q
CY2023Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q4	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q4	dei	Entity Registrant Name EntityRegistrantName	CLEARTRONIC, INC.
CY2023Q4	dei	Entity File Number EntityFileNumber	000-55329
CY2023Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2023Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	65-0958798
CY2023Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	28050 US Hwy 19N
CY2023Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	Clearwater
CY2023Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33761
CY2023Q4	dei	City Area Code CityAreaCode	813
CY2023Q4	dei	Local Phone Number LocalPhoneNumber	289-7620
CY2023Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q4	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q4	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q4	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Security12b Title Security12bTitle	Common stock Par Value $0.00001
CY2023Q4	dei	Trading Symbol TradingSymbol	CLRI
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	229160695	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	818525	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	516955	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	92665	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	63665	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	476565	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	545573	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	27646	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	21913	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	85575	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	68522	usd
CY2023Q4	clri	Due From Related Party Current DueFromRelatedPartyCurrent	53302	usd
CY2023Q4	clri	Interest Receivable Related Party Current InterestReceivableRelatedPartyCurrent	3427	usd
CY2023Q3	clri	Interest Receivable Related Party Current InterestReceivableRelatedPartyCurrent	2724	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1465040	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	1155687	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15168	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16526	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	121392	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	44373	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23932	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29914	usd
CY2023Q3	clri	Due From Related Party Non Current DueFromRelatedPartyNonCurrent	53302	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	53302	usd
CY2023Q4	us-gaap	Assets Assets	1625532	usd
CY2023Q3	us-gaap	Assets Assets	1299802	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	49537	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	85858	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1459667	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1105580	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	25267	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	24580	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1534471	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1216018	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	68217	usd
CY2023Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	72100	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6507	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	68217	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	78607	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1602688	usd
CY2023Q3	us-gaap	Liabilities Liabilities	1294625	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	229160695	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	229160695	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	229160695	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	229160695	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2291	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	2291	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15240104	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15240104	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15219625	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15237292	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	22844	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	5177	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1625532	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1299802	usd
CY2023Q4	us-gaap	Revenues Revenues	606047	usd
CY2022Q4	us-gaap	Revenues Revenues	506650	usd
CY2023Q4	us-gaap	Cost Of Revenue CostOfRevenue	95631	usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue	77491	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	510416	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	429159	usd
CY2023Q4	us-gaap	Selling Expense SellingExpense	120235	usd
CY2022Q4	us-gaap	Selling Expense SellingExpense	67831	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	405998	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	321898	usd
CY2023Q4	us-gaap	Depreciation Depreciation	1357	usd
CY2022Q4	us-gaap	Depreciation Depreciation	1080	usd
CY2023Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13559	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21815	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	541149	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	412624	usd
CY2023Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	44052	usd
CY2023Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4348	usd
CY2022Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	549	usd
CY2023Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	48400	usd
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	549	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17667	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17084	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	17667	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	17084	usd
CY2023Q4	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	10343	usd
CY2022Q4	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	10344	usd
CY2023Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7324	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6740	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	229160695	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228630043	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	599482330	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	599331678	shares
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	17667	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	17084	usd
CY2023Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1357	usd
CY2022Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1080	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	5982	usd
CY2023Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	44052	usd
CY2023Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	29000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-40008	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	24752	usd
CY2023Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5733	usd
CY2023Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	17756	usd
CY2022Q4	us-gaap	Increase Decrease In Notes Receivable Related Parties Current IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent	-9280	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	7731	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	32933	usd
CY2023Q4	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	350204	usd
CY2022Q4	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-223639	usd
CY2023Q4	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5820	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	378588	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-188014	usd
CY2023Q4	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	77018	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-77018	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	301570	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-188014	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	516955	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	468167	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	818525	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	80153	usd
CY2022Q4	us-gaap	Interest Paid Net InterestPaidNet	666	usd
CY2022Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	690	usd
CY2022Q4	clri	Cancellationof Shares Of Common Stock CancellationofSharesOfCommonStock	7	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	5177	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	17667	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	22844	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-51379	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	17084	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-34295	usd
CY2023Q4	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zwxFf8rorNV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_867_zFLX14VtJj51">USE OF ESTIMATES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing the consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and operations for the reporting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Significant estimates include the assumptions used in valuation of deferred tax assets, estimated useful life of property and equipment, valuation of inventory and allowance for credit losses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	10343	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	92665	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	63665	usd
CY2023Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	25500	usd
CY2023Q3	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	38250	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	85575	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	68522	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	121392	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2023Q4	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_z9pgAIXcQD61" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_865_zmlohbdjYnX1">CONCENTRATION OF CREDIT RISK</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company currently maintains cash balances at one FDIC-insured banking institution. Deposits held in non interest-bearing transaction accounts which are insured up to a maximum of $<span id="xdx_90C_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20231231_zbt7Djo8bx0e" title="Fdic insured amount">250,000</span> at all FDIC-insured institutions. As of December 31, 2023 and September 30, 2023, the Company had $<span id="xdx_90F_ecustom--AmountOfFdicInsuranceLimits_c20231001__20231231_pp0p0" title="Amount of fdic insurance limits">0</span> and $<span id="xdx_90D_ecustom--AmountOfFdicInsuranceLimits_c20221001__20221231_pp0p0" title="Amount of fdic insurance limits">118,140</span>, respectively, in excess of FDIC insured limits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	clri	Amount Of Fdic Insurance Limits AmountOfFdicInsuranceLimits	0	usd
CY2022Q4	clri	Amount Of Fdic Insurance Limits AmountOfFdicInsuranceLimits	118140	usd
CY2023Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13559	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21815	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	1527884	usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue	1177680	usd
CY2023Q4	us-gaap	Regulated Operating Revenue RegulatedOperatingRevenue	606047	usd
CY2022Q4	us-gaap	Regulated Operating Revenue RegulatedOperatingRevenue	506650	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1177680	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1125511	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	606047	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2184124	usd
CY2023Q4	us-gaap	Contract With Customer Asset Allowance For Credit Loss Writeoff ContractWithCustomerAssetAllowanceForCreditLossWriteoff	255843	usd
CY2023	us-gaap	Contract With Customer Asset Allowance For Credit Loss Writeoff ContractWithCustomerAssetAllowanceForCreditLossWriteoff	2131955	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1527844	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1177680	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2023Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7324	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6740	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	229160695	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228630043	shares
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7324	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6740	usd
CY2022Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	10344	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	17667	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	17084	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	229160695	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228630043	shares
CY2023Q4	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	370321635	shares
CY2022Q4	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	370701635	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	599482330	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	599331678	shares
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	27646	usd
CY2023Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	21913	usd
CY2023Q4	us-gaap	Advertising Expense AdvertisingExpense	22584	usd
CY2022Q4	us-gaap	Advertising Expense AdvertisingExpense	13419	usd
CY2023Q1	us-gaap	Area Of Land AreaOfLand	1145	sqft
CY2023Q4	us-gaap	Payments For Rent PaymentsForRent	2134	usd
CY2023Q4	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	2198	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23932	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29914	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	25267	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	31087	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2023Q4	clri	Amorization On Rightofuse Opeating Lease Asset AmorizationOnRightofuseOpeatingLeaseAsset	5982	usd
CY2023	clri	Amorization On Rightofuse Opeating Lease Asset AmorizationOnRightofuseOpeatingLeaseAsset	17949	usd
CY2023Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	584	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	2429	usd
CY2023Q4	us-gaap	Lease Cost LeaseCost	6566	usd
CY2023	us-gaap	Lease Cost LeaseCost	20378	usd
CY2023Q4	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	6402	usd
CY2023	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	19206	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	47863	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	19782	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6594	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	26376	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1109	usd
CY2023Q4	clri	Present Value Of Operating Lease Liability PresentValueOfOperatingLeaseLiability	25267	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	25267	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	28040	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	28040	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12872	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11514	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15168	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16526	usd
CY2023Q4	us-gaap	Depreciation Depreciation	1357	usd
CY2022Q4	us-gaap	Depreciation Depreciation	1080	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	121392	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	44373	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	121392	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	44373	usd
CY2023Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	0	usd
CY2022Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	0	usd
CY2023Q4	us-gaap	Cumulative Dividends CumulativeDividends	216524	usd
CY2023Q3	us-gaap	Cumulative Dividends CumulativeDividends	205658	usd
CY2023Q4	clri	Rent Expense RentExpense	0	usd
CY2022Q4	clri	Rent Expense RentExpense	2343	usd
CY2023Q4	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	12000	usd
CY2022Q4	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	9000	usd
CY2022Q4	clri	Advanced Amounts AdvancedAmounts	53302	usd
CY2022Q4	clri	Area Of Leased Facility AreaOfLeasedFacility	1145	sqft
CY2022Q4	clri	Monthly Rental Cost MonthlyRentalCost	2134	usd
CY2022Q4	clri	Monthly Rent MonthlyRent	2198	usd
CY2021Q4	clri	Area Of Leased Facility AreaOfLeasedFacility	2000	sqft
CY2021Q4	clri	Monthly Rental Cost MonthlyRentalCost	2200	usd
CY2021Q4	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2022-11-30
CY2023Q4	us-gaap	Royalty Expense RoyaltyExpense	9090	usd
CY2022Q4	us-gaap	Royalty Expense RoyaltyExpense	3640	usd
CY2023Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	44052	usd

Files In Submission

Name	View Source	Status
clri-20231231_cal.xml	Edgar Link	unprocessable
clri-20231231_def.xml	Edgar Link	unprocessable
0001091818-24-000016-index-headers.html	Edgar Link	pending
0001091818-24-000016-index.html	Edgar Link	pending
0001091818-24-000016.txt	Edgar Link	pending
0001091818-24-000016-xbrl.zip	Edgar Link	pending
clri-20231231.xsd	Edgar Link	pending
clri12312310q.htm	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
ex32_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
clri-20231231_lab.xml	Edgar Link	unprocessable
clri-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
clri12312310q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLRI
Cleartronic, Inc. Stock $clri

2024 Q1 Form 10-Q Financial Statement

#000109181824000016 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRI Cleartronic, Inc. Stock $clri

2024 Q1 Form 10-Q Financial Statement

#000109181824000016 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRI
Cleartronic, Inc. Stock $clri